How can Targeting Organelles be a Therapeutic Strategy?
Given the crucial roles of organelles in cancer cell survival and proliferation, targeting organelles offers a promising therapeutic strategy. Drugs that disrupt mitochondrial function, inhibit ER stress pathways, or impair the Golgi apparatus can effectively hinder tumor growth. For example, Bortezomib, a proteasome inhibitor, exploits ER stress to induce cancer cell death.
